At the BioMedical Engineering and Imaging Institute (BMEII), one of our main areas of research is the development of novel, transformative tools to better visualize and quantify the structure, function and metabolism of the brain. These tools are immediately translated to study the living human brain in the diseased and healthy state.
Over the last three decades, there has been unprecedented progress in the study of the brain. State-of-the-art brain imaging has allowed a first-time glimpse into the structure, functioning, and connectivity of the human and brain in both healthy and disease states.
Mount Sinai is one of the few institutions that has invested in the seven Tesla human MRI scanner that produces high-resolution images to visualize and measure changes in the brain that were previously undetectable. This advanced imaging technology makes it possible to noninvasively capture subtle neurological abnormalities that could allow for early detection of disease and open up the potential for treatment for patients who are refractory to drug treatments.
The use of creative engineering solutions in imaging could transform the management of neurological diseases with complex or subtle pathology, expand the use of minimally invasive treatment options, and bring us one step closer to unraveling the mystery of the human brain.
We perform research to push the performance of all neuroimaging modalities including functional MRI, diffusion MRI to study brain connectivity and perform tractography, spinal cord imaging, and MR spectroscopic imaging for the study of metabolism.
Brain imaging research is overseen by the Advanced Neuroimaging Research Program (ANRP), led by Dr. Priti Balchandani, Associate Professor of Radiology and Neuroscience. ANRP focuses on developing novel imaging technologies to diagnose and treat, a wide range of conditions, including epilepsy, brain tumors, psychiatric illnesses, multiple sclerosis, and spinal cord injury.
• Balchandani Lab
Focused on facilitating the most innovative
brain imaging research, while leveraging
technical and clinical advantages
Ultrahigh Field MRI Group
Devising creative engineering methods to overcome
some of the main limitations of operating at
high magnetic fields
Subtle changes in an individual’s heartbeat, which can be measured on an Apple Watch, are able to signal the onset of COVID-19 up to seven days before individuals are diagnosed with the infection. That preliminary observation was made by researchers at the Icahn...
Mount Sinai Hospital opens one of the first centers to study and treat people with what being called “Post-acute COVID Syndrome.”
Please click on the image to watch the 60 Minutes segment. New York, NY (November 22, 2020) — COVID-19 was initially thought to be a disease that was serious for the eldery and people with preexisting conditions. A potentially tough, but temporary respiratory illness...
Nanobiologic immunotherapy uses tiny, bioengineered material to harness immune systemNew York, NY (October 29, 2020) — A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it...
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Xueyan Mei, Hao-Chih Lee, […] Yang Yang
Nat Med (2020).
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Max L. Senders, Anu E. Meerwaldt, ... Willem J. M. Mulder
Nat. Nanotechnol. 15, 398–405 (2020).